Zonulin is a protein that helps regulate intestinal permeability by acting on the junctions that keep the cells of the intestinal wall sealed (the so-called “tight junctions”).
It is mainly produced in intestinal and liver cells and is also the precursor molecule of haptoglobin 2, which is why both terms are sometimes used interchangeably in the scientific literature. In addition to its role in permeability, it participates in innate intestinal immunity, and its levels have been found to be increased in various autoimmune diseases, such as coeliac disease or type 1 diabetes.
When the zonulin system is excessively activated, the tight junctions open more than normal, increasing intestinal permeability - what is commonly known as “leaky gut” - and allowing substances to pass through that can trigger immune system reactions.
This test measures, using the ELISA technique, the concentration of zonulin family peptides (ZFP) in a stool sample. Elevated levels have been associated with coeliac disease, type 1 diabetes mellitus, metabolic syndrome, obesity and other autoimmune and inflammatory diseases, such as multiple sclerosis, rheumatoid arthritis, asthma and inflammatory bowel diseases.
There are other faecal biomarkers, such as calprotectin, which are more commonly used to assess intestinal inflammation. Nevertheless, zonulin remains one of the reference parameters for studying the integrity of the intestinal barrier.